P - Caution when used during pregnancy
L - Caution when used during lactation
Drotaverine is an antispasmodic drug, structurally related to papaverine. Drotaverine is a selective inhibitor of phosphodiesterase 4, and has no anticholinergic effects.
A small 2003 study found drotaverine to be nearly 80% effective in treating renal colic. It has also been used to accelerate labor.
Drotaverine has antispasmodic effect mediated via inhibition of phosphodiesterase-IV, specific for smooth muscle. It has a rapid and direct action on the smooth muscle. It acts to correct cyclic AMP and Ca imbalance at the spastic site, thereby relieving smooth muscle spasm and pain.
Information Not Available
Vertigo, nausea, vomiting, dry mouth
Information Not Available
Exercise caution in patients with renal/hepatic/cardiac dysfunction. Pregnacy, lactation.
May attenuate the action of levodopa. Concurrent use of analgesics, antimuscarinics or benzodiazepines. Additive beneficial effect with concurrent use of analgesics, antimuscarinics or benzodiazepines.
Information Not Available
Oral
Antispasmodic
Adult: 40-80 mg tid.
Child: 1-6 yr: 20 mg 3-4 times daiily; >6 yr: 40 mg tid.
May be taken with or without food
Caution when used during pregnancy
Caution when used during lactation
Information Not Available
Information Not Available
Severe renal/hepatic/cardiac dysfunction. Porphyria.
Information Not Available
Information Not Available
You will hear from us only if the bid amount matches the minimum threshold and intended usage match our vision. You can resubmit another bid.